Valley Cities Recovery Place of Kent

Valley Cities Recovery Place of Kent

Services:
Assessment/Pre-treatment
• Comprehensive mental health assessment
• Screening for tobacco use
• Comprehensive substance use assessment
• Complete medical history/physical exam

Type of Opioid Treatment

• Lofexidine or Clonidine detoxification
• Accepts clients using MAT but prescribed elsewhere
• Buprenorphine maintenance
• Prescribes naltrexone
• Use methadone/buprenorphine for pain management or emergency dosing
• Prescribes buprenorphine
• Maintenance service with medically supervised withdrawal after stabilization

Facility Smoking Policy

• Smoking not permitted

Payment/Insurance/Funding Accepted

• Medicaid
• State-financed health insurance plan other than Medicaid
• Federal, or any government funding for substance use treatment programs
• IHS/Tribal/Urban (ITU) funds
• Federal military insurance (e.g., TRICARE)
• Private health insurance

Transitional Services

• Discharge Planning
• Naloxone and overdose education

Gender Accepted

• Female
• Male

Detoxification (medical withdrawal) Services

• Cocaine Detoxification
• Medication routinely used during detoxification
• Alcohol Detoxification
• Methamphetamines detoxification
• Benzodiazepines Detoxification
• Opioids detoxification

External Opioid Medications Source

• No formal relationship with prescribing entity

Treatment Approaches

• Substance use disorder counseling
• Motivational interviewing
• Brief intervention
• Cognitive behavioral therapy
• Trauma-related counseling

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Testing

• Testing for Hepatitis C (HCV)
• Metabolic syndrome monitoring
• Drug or alcohol urine screening
• HIV testing
• Breathalyzer or blood alcohol testing
• STD testing
• TB screening
• Testing for Hepatitis B (HBV)

Recovery Support Services

• Mentoring/peer support
• Assistance with obtaining social services

Language Services

• Sign language services for the deaf and hard of hearing

Facility Vaping Policy

• Vaping not permitted

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Ancillary Services

• Case management service
• Social skills development
• Mental health services

Type of Care

• Detoxification
• Substance use treatment
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Special Programs/Groups Offered

• Adult women
• Clients with co-occurring mental and substance use disorders
• Adult men

Education and Counseling Services

• Substance use disorder education
• Individual counseling
• Group counseling

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Age Groups Accepted

• Young Adults
• Adults

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Residential detoxification
• Residential/24-hour residential
• Short-term residential
• Long-term residential

Pharmacotherapies

• Clonidine
• Buprenorphine (extended-release, injectable)
• Nicotine replacement
• Naltrexone (extended-release, injectable)
• Medication for mental disorders
• Buprenorphine with naloxone
• Naltrexone (oral)
• Buprenorphine without naloxone

License/Certification/Accreditation

• State mental health department
• The Joint Commission
• State department of health
• State Substance use treatment agency